Portfolio company
Polyphron
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Polyphron manufactures donor-diverse human tissues and develops AI simulation models to help biotechnology and pharmaceutical companies test drug candidates and biological predictions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
PolyModels Hub
This company develops a digital platform for biopharma process development to help scientists design, simulate and optimise pharmaceutical manufacturing workflows.
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
Alp Bio
This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
Parallel Bio
This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.
CellType
This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.
